spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare Industry News:   Hologic 

Devices Oncology Litigation

 News Release - May 27, 2008

SenoRx Announces Court Dismisses Unfair Competition and False Advertising Claims

ALISO VIEJO, Calif., May 27, 2008 (Healthcare Sales & Marketing Network) -- SenoRx, Inc. (NasdaqGM:SENO ), a company that manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, today announced that the District Court issued an order relating to the lawsuit filed by Hologic and its wholly-owned subsidiaries, Cytyc Corporation and Cytyc LP, asserting claims of patent infringement, unfair competition and false advertising against SenoRx.


The order scheduled the claims construction hearing on the patent counts for June 25, 2008, and the trial in the case to start July 14, 2008. Pursuant to an agreement of the parties, the order also dismissed Hologic's unfair competition and false advertising claims under the Lanham Act and California state law, without prejudice.

About SenoRx

SenoRx (NasdaqGM:SENO ) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor(r) vacuum-assisted breast biopsy system and Contura(tm) MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx has recently launched several of its products through distributors in more than 15 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at http://www.senorx.com.

Source: SenoRx

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

Search: SenoRx 
Search:  Hologic 
Search: Cytyc 
Search: breast cancer 
Healthcare Industry NewsFeed  


FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!